DK0804200T3 - Anvendelse af noribogain-derivater til behandling af kemisk afhængighed hos pattedyr - Google Patents

Anvendelse af noribogain-derivater til behandling af kemisk afhængighed hos pattedyr

Info

Publication number
DK0804200T3
DK0804200T3 DK95927295T DK95927295T DK0804200T3 DK 0804200 T3 DK0804200 T3 DK 0804200T3 DK 95927295 T DK95927295 T DK 95927295T DK 95927295 T DK95927295 T DK 95927295T DK 0804200 T3 DK0804200 T3 DK 0804200T3
Authority
DK
Denmark
Prior art keywords
noribogain
mammals
derivatives
treatment
chemical dependence
Prior art date
Application number
DK95927295T
Other languages
English (en)
Inventor
Deborah Mash
Juan University Sanchez-Ramos
W Lee Hearn
Original Assignee
Nda Int Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nda Int Inc filed Critical Nda Int Inc
Application granted granted Critical
Publication of DK0804200T3 publication Critical patent/DK0804200T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DK95927295T 1994-07-25 1995-07-25 Anvendelse af noribogain-derivater til behandling af kemisk afhængighed hos pattedyr DK0804200T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US28018794A 1994-07-25 1994-07-25

Publications (1)

Publication Number Publication Date
DK0804200T3 true DK0804200T3 (da) 2006-09-11

Family

ID=23072046

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95927295T DK0804200T3 (da) 1994-07-25 1995-07-25 Anvendelse af noribogain-derivater til behandling af kemisk afhængighed hos pattedyr

Country Status (11)

Country Link
US (1) US6348456B1 (da)
EP (1) EP0804200B1 (da)
AT (1) ATE324897T1 (da)
AU (1) AU4613296A (da)
DE (1) DE69534975T2 (da)
DK (1) DK0804200T3 (da)
ES (1) ES2264562T3 (da)
IL (1) IL114726A (da)
MX (1) MX9701430A (da)
PT (1) PT804200E (da)
WO (1) WO1996003127A1 (da)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7220737B1 (en) 1997-09-04 2007-05-22 Novoneuron, Inc Noribogaine in the treatment of pain and drug addiction
ATE265213T1 (de) * 1997-09-04 2004-05-15 Novoneuron Inc Noribogain zur behandlung von schmerzen und drogenabhängigkeit
AU2003200404B2 (en) * 1997-09-04 2006-06-29 Demerx, Inc. Noribogaine in the treatment of pain and drug addiction
BR0106261A (pt) * 2001-12-26 2003-09-02 Fundacao Oswaldo Cruz Composições medicamentosas contendo alcalóides indólicos para o tratamento da aids
US20030153552A1 (en) * 2002-02-14 2003-08-14 Mash Deborah C. Method of treating chemical dependency in mammals and a composition therefor
GB2480632A (en) 2010-05-25 2011-11-30 Kythera Biopharmaceuticals Inc Preparation of 12-keto and 12-alpha-hydroxy steroids
US8362007B1 (en) 2010-05-11 2013-01-29 Demerx, Inc. Substituted noribogaine
US8765737B1 (en) 2010-05-11 2014-07-01 Demerx, Inc. Methods and compositions for preparing and purifying noribogaine
US9394294B2 (en) 2010-05-11 2016-07-19 Demerx, Inc. Methods and compositions for preparing and purifying noribogaine
US9586954B2 (en) 2010-06-22 2017-03-07 Demerx, Inc. N-substituted noribogaine prodrugs
US8741891B1 (en) 2010-06-22 2014-06-03 Demerx, Inc. N-substituted noribogaine prodrugs
US8802832B2 (en) 2010-06-22 2014-08-12 Demerx, Inc. Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
US8637648B1 (en) 2010-06-22 2014-01-28 Demerx, Inc. Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
RU2586296C2 (ru) * 2010-07-23 2016-06-10 Демеркс, Инк. Композиции норибогаина
AU2012202509B2 (en) * 2010-07-23 2014-02-13 Demerx, Inc. Noribogaine compositions
EP2481740B1 (en) 2011-01-26 2015-11-04 DemeRx, Inc. Methods and compositions for preparing noribogaine from voacangine
US9617274B1 (en) 2011-08-26 2017-04-11 Demerx, Inc. Synthetic noribogaine
CA2845007C (en) 2011-09-15 2020-09-29 Demerx, Inc. Ansolvate or crystalline polymorph noribogaine salts
EP2788355A4 (en) 2011-12-08 2015-10-21 Demerx Inc STEREOSELECTIVE TOTAL SYNTHESIS OF NORIBOGAIN
EP2788003A4 (en) * 2011-12-09 2015-05-27 Demerx Inc PHOSPHATESTER OF NORIBOGAIN
WO2013085849A2 (en) * 2011-12-09 2013-06-13 Demerx, Inc. Sulfate esters of noribogaine
US8877921B2 (en) 2012-01-25 2014-11-04 Demerx, Inc. Synthetic voacangine
US9150584B2 (en) 2012-01-25 2015-10-06 Demerx, Inc. Indole and benzofuran fused isoquinuclidene derivatives and processes for preparing them
WO2013112163A1 (en) * 2012-01-25 2013-08-01 Demerx, Inc. Indole and benzofuran fused isoquinuclidene derivatives and processes for preparing them
US9045481B2 (en) 2012-12-20 2015-06-02 Demerx, Inc. Substituted noribogaine
US9783535B2 (en) 2012-12-20 2017-10-10 Demerx, Inc. Substituted noribogaine
US8940728B2 (en) 2012-12-20 2015-01-27 Demerx, Inc. Substituted noribogaine
CA2942638A1 (en) * 2013-03-15 2014-09-18 Demerx, Inc. Method for noribogaine treatment of addiction in patients on methadone
EP3096794A2 (en) * 2014-01-24 2016-11-30 DemeRx, Inc. Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
US9345711B2 (en) 2014-02-18 2016-05-24 Demerx, Inc. Methods for acute and long-term treatment of drug addiction
KR20160124829A (ko) * 2014-02-18 2016-10-28 데메알엑스, 인크. 노르이보가인 및 관련된 화합물을 이용하는 치료 방법
JP2017509612A (ja) 2014-02-18 2017-04-06 デメルクス，インコーポレイテッド 薬物中毒の急性および長期間での治療方法。
US9561232B2 (en) 2014-02-18 2017-02-07 Demerx, Inc. Low dose noribogaine for treating nicotine addiction and preventing relapse of nicotine use
US9591978B2 (en) 2014-03-13 2017-03-14 Demerx, Inc. Methods and compositions for pre-screening patients for treatment with noribogaine
US9550789B2 (en) 2014-06-18 2017-01-24 Demerx, Inc. Halogenated indole and benzofuran derivatives of isoquinuclidene and processes for preparing them
US9549935B2 (en) 2014-07-14 2017-01-24 Demerx, Inc. Methods and compositions for treating migraines using noribogaine
WO2016086194A1 (en) 2014-11-26 2016-06-02 Demerx, Inc. Methods and compositions for potentiating the action of opioid analgesics using iboga alkaloids
GB2571696B (en) 2017-10-09 2020-05-27 Compass Pathways Ltd Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
CN114206349A (zh) 2019-04-17 2022-03-18 指南针探路者有限公司 治疗神经认知障碍、慢性疼痛及减轻炎症的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3516989A (en) * 1967-10-02 1970-06-23 American Home Prod Intermediates for total synthesis of iboga alkaloids and means of preparation
US4499096A (en) * 1983-11-18 1985-02-12 Lotsof Howard S Rapid method for interrupting the narcotic addiction syndrome
US4587243A (en) * 1985-07-15 1986-05-06 Lotsof Howard S Rapid method for interrupting the ***e and amphetamine abuse syndrome
US5152994A (en) * 1990-05-31 1992-10-06 Lotsof Howard S Rapid method for interrupting or attenuating poly-drug dependency syndromes
US5591738A (en) * 1994-10-14 1997-01-07 Nda International, Inc. Method of treating chemical dependency using β-carboline alkaloids, derivatives and salts thereof

Also Published As

Publication number Publication date
ES2264562T3 (es) 2007-01-01
US6348456B1 (en) 2002-02-19
DE69534975D1 (de) 2006-06-08
PT804200E (pt) 2006-09-29
IL114726A (en) 2002-04-21
WO1996003127A1 (en) 1996-02-08
ATE324897T1 (de) 2006-06-15
DE69534975T2 (de) 2007-01-11
EP0804200A4 (en) 1999-06-23
EP0804200B1 (en) 2006-05-03
AU4613296A (en) 1996-04-19
EP0804200A1 (en) 1997-11-05
IL114726A0 (en) 1995-11-27
MX9701430A (es) 1997-12-31

Similar Documents

Publication Publication Date Title
DK0804200T3 (da) Anvendelse af noribogain-derivater til behandling af kemisk afhængighed hos pattedyr
DE3270307D1 (en) Succinimide derivates and process for preparation thereof
ID17851A (id) Persenyawaan heterosiklis, produksi dan pemakaiannya
TW370450B (en) Substituted 1H-3-aryl-pyrrolidine-2,4-dione derivatives
BG105457A (en) Method for the preparation of citalopram
DE3781716D1 (de) Mittel zur ortsspezifischen alkylierung.
HK1072770A1 (en) Bicyclic compound
ATE263771T1 (de) Totalsynthese von acylfulvenen mit antitumorwirkung
EP0945764A3 (en) Photoresist composition
NZ503912A (en) Piperidinylaminomethyl trifluoromethyl cyclic ether compounds and their use as substance P antagonists
EA200100310A1 (ru) Кислородсодержащие гетероциклические соединения
MX170732B (es) Composicion de derivados de succinimida y su uso
ES8706690A1 (es) Un procedimiento para la preparacion de nuevos derivados de penem.
JO2433B1 (en) Preparation of heterocyclic lindane landscapes
SE0003186D0 (sv) New process
MY133207A (en) Substituted benzolactam compaunds
YU166291A (sh) Indenoindol jedinjenja
DE60004669D1 (de) Indolocarbazolalkaloide aus einer marinen actinomycete
BR9911402A (pt) Uso de corantes amino azóicos, e, compostos
DE60007848D1 (de) Herstellung von 2'-substitutierter rns
TR199900922T2 (xx) Lipoprotein (A)'n�n plazma seviyesini d���rmek i�in bir y�ntem.
DE60114889D1 (de) Verfahren zur herstellung von fluconazole und kristallmodifikationen davon
EA199800931A1 (ru) Способ получения ингибиторов фосфодиэстеразы iv
WO2002100804A3 (en) Novel use of sulfamic acids as resolving agent.
TW270112B (en) Novel compounds capable of lowering blood-lipid activity and its production process and its novel intermediates